Iron Peptides: 971 Qualified Opportunities in 11 Weeks
Campaign Overview
IRON Peptides is a premium research-peptide brand built on pharmaceutical-grade quality and rigorous third-party testing. With a catalog of more than 100 compounds — including Retatrutide, Tesamorelin, BPC-157, GHK-Cu, and SS-31 — IRON positions itself as the higher-standard alternative to discount suppliers that dominate the category. Its affiliate network spans health creators, practitioners, and fitness professionals who stake their own reputation on the products they recommend.
IRON Peptides partnered with Lead Gen Jay to build a diversified outbound motion targeting the people most likely to become high-value affiliates: health creators, fitness professionals, local health practices, and medical sales reps across the United States. The challenge was unusual. IRON already ran a strong outbound motion of its own, generating meetings every day across hundreds of mailboxes. The question was not whether cold email could work — it was whether a more targeted, sequenced, and diversified approach could produce qualified interest more efficiently than broad, single-touch outreach, and open affiliate channels the existing motion was not reaching.
IRON's best affiliates are creators and practitioners who are close to the product, skeptical of sales language, and selective about whose name they attach to theirs. Reaching them meant matching the sophistication of the audience with the sophistication of the targeting and the copy.
Strategy
Rather than betting the campaign on a single assumed audience, Lead Gen Jay launched three segments in parallel, each with its own list, filters, messaging, and sender: health creators and fitness professionals, local health businesses, and medical sales reps. The goal was to find, quickly and cheaply, where the affiliate offer traveled furthest.
The data answered fast. Health creators emerged as the clear winner, converting interested prospects at roughly ten times the rate of the other two segments. Local health businesses and medical sales reps hit a ceiling early, so investment there was cut and the full weight of the campaign moved behind the segment that was working. Finding that answer in weeks rather than months is budget saved.
Two decisions made the winning segment convert as well as it did. First, the copy was anchored on a live market event: a category-leading competitor had recently been shut down, leaving its followers and customers actively searching for a new source. That timing gave every email a genuine reason to exist. Second, instead of a single touch, each prospect moved through a four-email sequence carrying a layered proof stack — real purity data, third-party testing results, and concrete revenue numbers. Precision targeting created the opening, and the sequence and proof closed it.
Key Metrics
- Campaign Duration: 11 weeks (April 28 – July 14, 2026)
- Prospects Contacted: 60,157
- Emails Sent: 154,445
- Total Replies: 1,732
- Qualified Opportunities: 971
- Interested Rate (share of replies that were positive): 56.1%
- Bounce Rate: 1.18%
- Spam Complaints: 0
The 971 qualified opportunities are the headline, but the more telling number is the interested rate of 56.1% — meaning more than half of every reply the campaigns generated was genuine interest rather than a brush-off or an auto-responder. Volume and quality at the same time.
Best-Performing Campaign
Health Creators Segment
The health creator segment was the standout performer across the entire campaign. Outperforming the other segments by a substantial margin, it became the concentrated focus of the campaign after early data made the gap impossible to ignore.
- Prospects Contacted: 18,387
- Qualified Opportunities: 864
- Reply Rate: 7.42%
- Positive Reply Rate: 4.7%
- Interested Rate (share of replies): 63.3%
- Bounce Rate: 0.22%
For context, the broad outreach IRON was already running against the same audience produced a positive reply rate closer to 1.9%. Same offer, same inboxes — the difference was targeting, timing, and copy. The health creator segment alone accounted for 864 of the campaign's 971 total qualified opportunities, confirming that the decision to concentrate resources on the winning segment was the right one.
Success Factors
Parallel Segment Testing
Instead of betting on a single assumed audience, Lead Gen Jay ran three segments simultaneously and let performance data decide where to focus. This surfaced the winning audience early and stopped the budget from draining into segments that were never going to convert at scale. The willingness to test broadly and cut fast was the difference between spreading effort thin and concentrating it where it paid off.
A Timing Wedge That Created Real Urgency
The copy was built around a live market event — the shutdown of a category-leading competitor — that left a large, motivated audience actively looking for a new source. This gave every email a credible reason to land in that moment, rather than relying on generic offer language. The best cold email does not manufacture urgency; it attaches to urgency that already exists. For an audience as sophisticated as health creators, that distinction matters.
A Layered Proof Stack Delivered Over a Sequence
Rather than a single pitch, each prospect moved through a four-email sequence carrying concrete proof: pharmaceutical-grade purity figures, third-party testing documentation, and real revenue numbers from the product line. For a health-literate, skeptical audience, that stack of specifics did the persuading that adjectives cannot. The sequence also gave the message more than one chance to connect, rather than living or dying on the strength of a single send.
Clean Sending That Protected the Whole Operation
Zero spam complaints across more than 154,000 emails, with bounce rate held to 1.18%, is not an accident. Verified lists and disciplined sending practices kept deliverability strong throughout the entire eleven-week window. Because IRON's existing outbound motion relies on the same domain reputation, this discipline protected revenue channels well beyond the campaign itself — a compounding benefit that extends long after the campaign closes.
Conclusion
IRON Peptides' campaign demonstrates that even a mature outbound operation — already producing meetings daily — can be meaningfully extended when a new channel is built with precision rather than volume. Standard broad outreach has its place, but a targeted pivot to the right audience, at the right moment, with the right proof unlocked a far more efficient stream of qualified interest.
With 971 qualified opportunities generated across eleven weeks, more than half of every reply landing as genuine interest, and zero spam complaints across 154,000 emails, the campaign delivered volume and quality simultaneously. The 971 qualified opportunities represent a substantial pipeline of potential affiliates. In an affiliate model built on recurring commission, where a single productive creator or practice can drive sales month after month, the value of a qualified opportunity is measured not by a one-time deal but by the lifetime of the partnership it can start.
Beyond the immediate pipeline, the campaign produced a validated, repeatable playbook. Lead Gen Jay now knows which segment converts, which angle lands, and which proof points move this specific audience. The next phase is not a fresh experiment — it is a matter of feeding proven copy with fresh volume. The combination of parallel segment testing, a live timing wedge, a layered proof stack, and disciplined sending has created a channel that IRON can scale with confidence.
Past results do not guarantee future results. Individual outcomes vary based on industry, offer, and implementation.
Want Results Like These?
Book a free strategy call and we'll build a custom plan for your business.
Book Your Free Strategy Call